160 related articles for article (PubMed ID: 37870297)
1. ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS.
Müller M; Herrmann A; Fujita S; Uriu K; Kruth C; Strange A; Kolberg JE; Schneider M; Ito J; Müller MA; Drosten C; Ensser A; ; Sato K; Sauter D
EMBO Rep; 2023 Dec; 24(12):e57137. PubMed ID: 37870297
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
3. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity.
Stewart H; Lu Y; O'Keefe S; Valpadashi A; Cruz-Zaragoza LD; Michel HA; Nguyen SK; Carnell GW; Lukhovitskaya N; Milligan R; Adewusi Y; Jungreis I; Lulla V; Matthews DA; High S; Rehling P; Emmott E; Heeney JL; Davidson AD; Edgar JR; Smith GL; Firth AE
iScience; 2023 Nov; 26(11):108080. PubMed ID: 37860693
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
5. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
[TBL] [Abstract][Full Text] [Related]
7. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
Firth AE
J Gen Virol; 2020 Oct; 101(10):1085-1089. PubMed ID: 32667280
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.
Li X; Hou P; Ma W; Wang X; Wang H; Yu Z; Chang H; Wang T; Jin S; Wang X; Wang W; Zhao Y; Zhao Y; Xu C; Ma X; Gao Y; He H
Cell Mol Immunol; 2022 Jan; 19(1):67-78. PubMed ID: 34845370
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production.
Chen K; Xiao F; Hu D; Ge W; Tian M; Wang W; Pan P; Wu K; Wu J
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396605
[TBL] [Abstract][Full Text] [Related]
12. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.
Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452305
[TBL] [Abstract][Full Text] [Related]
14. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH
J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress, and autophagic flux.
Mozzi A; Oldani M; Forcella ME; Vantaggiato C; Cappelletti G; Pontremoli C; Valenti F; Forni D; Saresella M; Biasin M; Sironi M; Fusi P; Cagliani R
iScience; 2023 Jul; 26(7):107118. PubMed ID: 37361873
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.
Deng J; Zheng SN; Xiao Y; Nan ML; Zhang J; Han L; Zheng Y; Yu Y; Ding Q; Gao C; Wang PH
J Med Virol; 2023 Apr; 95(4):e28680. PubMed ID: 36929724
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.
Esser-Nobis K; Hatfield LD; Gale M
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931
[TBL] [Abstract][Full Text] [Related]
18. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
19. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
Front Immunol; 2022; 13():947272. PubMed ID: 36032116
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
